stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Dermata Therapeutics IncDRMA
$0.50954.23%-0.0225

Dermata Therapeutics Inc (DRMA)

Dermata Therapeutics Inc stock is traded at $0.5095, with a volume of 26,595. It is down -4.23% in the last 24 hours and down -41.43% over the past month. Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
Previous Close:
$0.532
Open:
$0.5319
24h Volume:
26,595
Relative Volume:
0.44
Market Cap:
$2.51M
Revenue:
-
Net Income/Loss:
-$7.10M
P/E Ratio:
-
EPS:
-$5.31
Net Cash Flow:
-$8.30M
1W Performance:
-17.98%
1M Performance:
-41.43%
6M Performance:
-59.24%
1Y Performance:
-79.62%
1-Day Range:
$0.5004$0.547
1-Week Range:
$0.5004$0.68
52-Week Range:
$0.5004$4.66

Dermata Therapeutics Inc Stock (DRMA) Company Profile

Name
Dermata Therapeutics Inc
Phone
(858)-223-0882
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, USA
Employee
9
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
DRMA's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Dermata Therapeutics Inc Stock (DRMA) Financials Data

Similar to DRMA